Globus Medical (GMED) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Globus Medical Reports First Quarter 2017 Results
May 3, 2017 4:15 PM EDTAUDUBON, Pa., May 03, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2017.
Worldwide sales were $155.8 million, an increase of 11.9% as reported, or 12.1% in constant currencyFirst quarter net income was $28.7 million, or 18.4% of salesDiluted earnings per share (EPS) were $0.30Non-GAAP diluted EPS were $0.32Non-GAAP adjusted EBITDA was 37.1% of salesDavid Paul, Chairman and CEO said, Our worldwide sales for the first quarter were $155.8 million, an increase of 11.9%... More
